Design Therapeutics Stock (NASDAQ: DSGN) stock price, news, charts, stock research, profile.
You can purchase shares of Design Therapeutics (NASDAQ:DSGN) through any online brokerage.
Other companies in Design Therapeutics’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Zentalis Pharma (NASDAQ:ZNTL), Korro Bio (NASDAQ:KRRO), Lexeo Therapeutics (NASDAQ:LXEO) and Emergent BioSolutions (NYSE:EBS).
Design Therapeutics has a consensus price target of $6.75.
The stock price for Design Therapeutics (NASDAQ: DSGN) is $5.38 last updated September 25, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Design Therapeutics.
Design Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Design Therapeutics.
Design Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.